Skip to main content

Table 5 Rates of medication coverage for patients with diabetes, for the first quarter of each year, 2010 to 2016, administrative cohort

From: Impact of the diabetes Canada guideline dissemination strategy on dispensed vascular protective medications for older patients in Ontario, Canada: a linked EMR and administrative data study

Drug

2010Q1

2011Q1

2012Q1

2013Q1

2014Q1

2015Q1

2016Q1

STATIN

60.91%

62.62%

62.83%

63.76%

63.83%

64.18%

64.48%

ACEi or ARB

61.94%

61.80%

60.87%

60.72%

60.30%

59.72%

59.16%

ANTIPLATELETS*

10.23%

9.97%

9.40%

8.79%

8.14%

7.48%

6.91%

PPI

22.92%

23.91%

24.57%

25.56%

26.14%

26.72%

27.34%

  1. *patients with a history of myocardial infarct were excluded
  2. ACEi: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blockers; PPI: proton pump inhibitor
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us